Leukemia Research
Volume 24, Issue 4 , Pages 359-366 , April 2000

Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia

Received 19 July 1999 ,Accepted 6 November 1999.

References 

  1. Lowenthal RM, Marsden KA. Myelodysplastic syndromes. Int. J. Hematol. 1997;65:319
  2. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. Proposals for the classifications of the myelodysplastic syndromes. Br. J. Haematol. 1982;51:189
  3. Willemze R, Fibbe WE, Falkenburg JHF, Kluin-Nelemans JC, Kluin PM, Landegent JE. Biology and treatment of myelodysplastic syndromes: developments in the past decade. Ann. Hematol. 1993;66:107
  4. Kerkhofs H, Hermans J, Haak HL, Leeksma CH. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol 1987;65:73.
  5. Yoshida Y, Oguma S, Uchino H, Maekawa T. Refractory myelodysplastic anaemias with hypocellular bone marrow. J. Clin. Pathol. 1988;41:763
  6. Nand S, Godwin JE. Hypoplastic myelodysplastic syndrome. Cancer. 1988;62:958
  7. Orazi A, Albitar M, Heerema NA, Haskins S, Neiman RS. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am. J. Clin. Pathol. 1997;107:268
  8. Appelbaum FR, Barrall J, Storb R, Ramberg R, Doney K, Sale GE, et al. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp. Hematol. 1987;15:1134
  9. Mufti GJ, Hamblin TJ, Lee-Potter JP. The aplasia-leukaemia syndrome. Acta Haematol. 1983;69:349
  10. Orlandi E, Alessandrino EP, Caldera D, Bernasconi C. Adult leukemia developing after aplastic anemia. Acta Haematol. 1988;79:174
  11. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B. Late haematological complications in aplastic anaemia. Br. J. Haematol. 1988;69:413
  12. Greenberg P, Cox C, LeMeau MM, Fenaux P, Morel P, Sanz M, et al. International scoring systems for evaluating prognosis in myelodysplastic syndromes. Blood. 1998;19:1100
  13. Toyama K, Ohyashiki K, Yoshida Y, Abe T, Asano S, Hirai H, et al. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes. Int. J. Hematol. 1993;58:53
  14. Biesma DH, van den Tweel JG, Verdonck LF. Immunosuppressive therapy for hypoplastic myelodysplastic syndromes. Cancer. 1997;79:1548
  15. Marsh JC, Geary CG. Is aplastic anemia a pre-leukemic disorder?. Br. J. Haematol. 1991;77:447
  16. Simmons DL, Satterthwaite AB, Tenen DG, Seed B. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J. Immunol. 1992;148:267
  17. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M. Human bone marrow CD34− cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp. Hematol. 1998;26:353
  18. Goodell MA, Rosenzweig M, Kin H, Marks DF, DeMaria M, Paradis G, et al. Dye efflux studies suggest that hepatopoietic stem cells expressing low or undetectable levels of CD34 antigens exist in multiple species. Nat. Med. 1997;3:1337
  19. Thomas ML. The leukocyte common antigen family. Annu. Rev. Immunol. 1989;7:339
  20. Borowitz MJ, Guenther KL, Shults KE, Stelzer GT. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three color analysis. Am. J. Clin. Pathol. 1993;100:534
  21. Lacombe F, Durrieu F, Briais A, Dumain P, Belloc F, Bascans E, et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia. 1997;11:1878
  22. Andrews RG, Singer JW, Bernstein ID. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J. Exp. Med. 1989;169:1721
  23. Buhring HJ, Asenbauer B, Katrilaka K, Hummel G, Busch FW. Sequential expression of CD34 and CD33 antigens on meyloid colony-forming cells. Eur. J. Haematol. 1989;42:143
  24. Tricot GJ. Minimal diagnostic criteria for the myelodysplastic syndrome in clinical practice. Leuk. Res. 1992;16:5
  25. Ost A, Reizenstein P. Minimal diagnostic criteria for the myelodysplastic syndrome. Leuk. Res. 1992;16:9
  26. Mann HB, Whitney DR. On a test of whether one of two variables is stochastically larger than the other. Ann. Math. Stat. 1947;18:50
  27. Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann. New York Acad. Sci. 1993;677:265
  28. Rainer RO, Hodges L, Stelzer GT. CD45 gating correlates with bone marrow differential. Cytometry. 1995;22:139
  29. Funaro A, Spagnoli GC, Ausiello CM, Alessio M, Roggero S, Delia D, et al. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J. Immunol. 1990;145:2390
  30. White S, Taetle R, Seligman PA, Rutherford M, Trowbridge IS. Combinations of Anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res. 1990;50:6295
  31. Simmons D, Seed B. Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells. J. Immunol. 1988;141:2797
  32. Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J. Clin. Invest. 1989;83:1299
  33. Haynes BF, Denning SM, Singer KH, Kurtzberg J. Ontogeny of T-cell precursors: a model for the initial stages of human T-cell development. Immunol. Today. 1989;10:87
  34. Tedder TF, Isaacs CM. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J. Immunol. 1989;143:712
  35. Wright SD, Ramos R, Tobias P, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249:1431
  36. Lu L, Walker D, Broxmeyer HE, Hoffman R, Hu W, Walker E. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies. J. Immunol. 1987;139:1823
  37. Karakantza M, Cavenagh JD, Gordon-Smith EC, Gibson FM. Adhesion molecule expression on CD34+ progeitor cells from normal and aplastic anaemia bone marrow. Br J Haematol 1995;91:800.
  38. Guyotat D, Campos L, Thomas X, Vila L, Shi ZH, Charrin C, et al. Myelodysplasticsyndromes: a study of surface markers and in vitro growth patterns. Am. J. Hematol. 1990;34:26
  39. Kerndrup G, Bendix-Hansen K, Pedersen B, Ellegaard J, Hokland P. Analysis of leucocyte differentiation antigens in blood and bone marrow in patients with refractory anaemia(RA) and RA with sideroblasts. Prognostic implications of sequential and follow-up data. Eur. J. Haematol. 1988;41:368
  40. Kuiper-Kramer PA, Huisman CMS, Van der Molen-Sinke, Abbes A, Van Eijk HG. The expression of transferrin receptors on erythroblasts in anaemia of chronic disease, myelodysplastic syndromes and iron deficiency. Acta Haematol 1997;97:127.
  41. Glasova M, Konikova E, Stasakova J, Babusikova O. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells. Neoplasma. 1998;45:88
  42. Santini V, Ferrini PR. Differentiation therapy of myelodysplastic syndromes: fact or fiction?. Br. J. Haematol. 1998;102:1124

PII: S0145-2126(99)00194-0

Leukemia Research
Volume 24, Issue 4 , Pages 359-366 , April 2000

Article Tools

* Image Usage & Resolution